- Associate Professor Justin Denholm
Medical Director, Victorian Tuberculosis Program at Melbourne Health; Principal Research Fellow, Department of Microbiology and Immunology, University of Melbourne; The Peter Doherty Institute for Infection and Immunity
Q&A: Dexamethasone and COVID-19
A UK trial finds dexamethasone is “the first drug shown to improve survival in COVID-19”. A University of Melbourne expert explains what it is and how it works.
From decades to days: 3D modelling tuberculosis
3D modelling of TB mutations means doctors could soon tailor individual treatments for the disease in days, not years, say University of Melbourne researchers.
Tuberculosis: Still a major killer
University of Melbourne researchers estimate for first time the burden of tuberculosis on adolescents and young adults, a group often ignored in disease control